Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
复制标题
DOI:
10.2337/dc10-2411
复制
发表时间:
2011-09
期刊:
影响因子:
16.2
通讯作者:
Amiel SA
中科院分区:
文献类型:
--
作者:
Choudhary P;Shin J;Wang Y;Evans ML;Hammond PJ;Kerr D;Shaw JA;Pickup JC;Amiel SA
To evaluate a sensor-augmented insulin pump with a low glucose suspend (LGS) feature that automatically suspends basal insulin delivery for up to 2 h in response to sensor-detected hypoglycemia. The LGS feature of the Paradigm Veo insulin pump (Medtronic, Inc., Northridge, CA) was tested for 3 weeks in 31 adults with type 1 diabetes. There were 166 episodes of LGS: 66% of daytime LGS episodes were terminated within 10 min, and 20 episodes lasted the maximum 2 h. LGS use was associated with reduced nocturnal duration ≤2.2 mmol/L in those in the highest quartile of nocturnal hypoglycemia at baseline (median 46.2 vs. 1.8 min/day, P = 0.02 [LGS-OFF vs. LGS-ON]). Median sensor glucose was 3.9 mmol/L after 2-h LGS and 8.2 mmol/L at 2 h after basal restart. Use of an insulin pump with LGS was associated with reduced nocturnal hypoglycemia in those at greatest risk and was well accepted by patients.
登录
查看更多内容
影响因子:
158.5
作者:
Jones, TW;Porter, P;Tamborlane, WV
通讯作者:
Tamborlane, WV
影响因子:
5.8
作者:
Guerci, B;Meyer, L;Drouin, P
通讯作者:
Drouin, P
影响因子:
8.2
作者:
O'Connell, M. A.;Donath, S.;Cameron, F. J.
通讯作者:
Cameron, F. J.
影响因子:
158.5
作者:
Tamborlane, William V.;Beck, Roy W.;Xing, Dongyuan
通讯作者:
Xing, Dongyuan
影响因子:
16.2
作者:
Raccah D;Sulmont V;Reznik Y;Guerci B;Renard E;Hanaire H;Jeandidier N;Nicolino M
通讯作者:
Nicolino M